J Am Pharm Assoc (2003). 2022 Jul-Aug;62(4):1189-1196. doi: 10.1016/j.japh.2022.01.012. Epub 2022 Jan 19.
Older adults experiencing hyperpolypharmacy (use of 10 or more medications) are at an increased risk of cognitive impairment and functional decline. Deprescribing, where medications are stopped or tapered, is one strategy to mitigate risks.
The primary objective of our study was to use a card sorting activity to explore how older adults experiencing hyperpolypharmacy make hypothetical deprescribing decisions.
We recruited participants using our institutional research recruitment website between February and November 2020. Participant spoke with a research assistant to create a medication list and then completed an interview using card sorting activity to demonstrate how they would make hypothetical decisions about continuing or deprescribing their medications. Data from the card sorting activities and interviews were organized via Excel (Microsoft Corporation). We used the Pharmacy Quality Alliance Medication Therapy Problems Categories Framework to analyze participant's reasons for considering deprescribing. The study was deemed exempt by the institutional review board.
Among the 26 participants, 14 (54%) identified as female, 19 (73%) were white, and 24 (92%) reported good or very good health. Participants reported a total of 405 medications (average 16, range 10-30). A total of 19 participants (73%) were interested in deprescribing 94 medications (23%), including stopping 68 medications (72%) and lowering the dose or frequency of 26 medications (28%). Common rationales for wanting to stop a medication included perceived lack of indication (n = 30, 32%), adherence (general preference to not take the medication) (n = 20, 21%), lack of effectiveness (n = 17, 18%), and concerns about safety (n = 14, 15%). We were unable to categorize 13 rationales (14%).
Most older adults experiencing hyperpolypharmacy were willing to consider deprescribing at least one medication. Future research is needed to identify whether a card sorting medication reflection activity can be used to provoke conversations about deprescribing between patients and primary care providers.
服用十种或更多药物的老年患者认知障碍和功能下降的风险增加。减少药物剂量是降低风险的一种策略。
本研究的主要目的是使用卡片分类活动来探索患有药物超量的老年人如何做出假设性的减药决策。
我们于 2020 年 2 月至 11 月期间通过我们的机构研究招聘网站招募参与者。参与者与研究助理交谈以创建药物清单,然后通过卡片分类活动完成访谈,以展示他们将如何继续或减少他们的药物治疗。数据来自卡片分类活动和访谈,使用 Excel(微软公司)进行组织。我们使用药学质量联盟药物治疗问题分类框架分析参与者考虑减少药物剂量的原因。该研究被机构审查委员会豁免。
在 26 名参与者中,14 名(54%)为女性,19 名(73%)为白人,24 名(92%)报告健康状况良好或非常好。参与者共报告了 405 种药物(平均 16 种,范围 10-30 种)。共有 19 名参与者(73%)对减少 94 种药物(23%)的剂量感兴趣,包括停止 68 种药物(72%)和降低 26 种药物的剂量或频率(28%)。想要停止用药的常见理由包括认为缺乏适应证(n=30,32%)、(出于一般偏好而)不能坚持服药(n=20,21%)、无效(n=17,18%)和担心安全问题(n=14,15%)。我们无法对 13 种理由进行分类(14%)。
大多数患有药物超量的老年患者都愿意考虑减少至少一种药物的剂量。需要进一步研究确定卡片分类药物反思活动是否可用于促进患者和初级保健提供者之间的减药讨论。